科源制药：股东拟减持不超过1%公司股份

Core Viewpoint - The company Koyuan Pharmaceutical (301281) announced on January 19 that a shareholder, Wenze Hong, who holds 5% of the shares, plans to reduce his stake by no more than 1,082,900 shares, which represents 1% of the company's total share capital [1]. Summary by Category - Shareholder Activity - Wenze Hong, a 5% shareholder, intends to reduce his holdings by up to 1,082,900 shares [1]. - Impact on Company - The planned reduction in shares represents 1% of Koyuan Pharmaceutical's total share capital, indicating a significant move by a major shareholder [1].